Clinical trial · Observational
The Impact of Inflammatory Adhesion on the Prognosis of Colon Cancer Patients
The Impact of Tumor-associated Inflammatory Adhesion on the Prognosis of Colon Cancer Patients: a Study Based on the SEER and Chinese Multi-center Databases
NCT06655285CI-TRIAL-00082318completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to explore the impact of tumor-associated inflammatory adhesion on the prognosis of colon cancer patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colon Cancer | Malignant Colon Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| This was a retrospective study and no patient intervention was performed. | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- the U.S. National Cancer Center SEER database
- description
- SEER\*Stat software (version 8.4.3) collected 17 registries cohort data on colon cancer patients between 2010 and 2019.
- interventionNames
- Other: This was a retrospective study and no patient intervention was performed.
- label
- Chinese multi-center database
- description
- Chinese multi-center database includes patients from January 2010 to December 2021 at 3 institutions.
- interventionNames
- Other: This was a retrospective study and no patient intervention was performed.
Primary outcomes (3)
- measure
- Overall survival time (OS)
- timeFrame
- up to 10 years
- description
- OS, defined as the time from the first diagnosis to death from any cause or the last follow-up for surviving patients
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 99 Years
Show eligibility criteria text
Inclusion Criteria: 1. The patient was pathologically diagnosed as colon adenocarcinoma by endoscopic biopsy before operation. 2. All patients were considered to have tumors invading adjacent organs during surgery 3. All patients underwent radical surgery. Exclusion Criteria: 1\. Patients with distant metastasis, recurrent colon cancer and pT4b CRC were excluded.
References
Publications (0)
Data not yet available
No reference posted for this study.